Shenzhen Genocury Biotechnology Co., Ltd.
PrivateLast Round
Series D
Nov 1, 2025
Est. Valuation
$610M
Total Funding Raised
$63.7M
Company Overview
Shenzhen Genocury Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a Series D round in November 2025.
Shenzhen Genocury Biotechnology Co., Ltd. is a biotechnology company that focuses on the research and development of gene and cell therapies for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shenzhen Genocury Biotechnology Co., Ltd. Comparables
Compare Shenzhen Genocury Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Umoja Biopharma | 83% | |
| CREATE Medicines | 79% | |
| Alaya.bio | 78% |
For institutional investors. Book with your work email.
Shenzhen Genocury Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Nov 1, 2025 | ||||
| Series A | Jun 18, 2024 | ||||
| Angel Extension | May 15, 2024 | ||||
| Early Funding | Apr 21, 2023 | ||||
| Angel | Jan 31, 2023 | ||||
Strategic | Jan 14, 2019 |
For institutional investors. Book with your work email.
Shenzhen Genocury Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beijing Chang Development | Series D |
| Tianjin Venture Capital Management Co., Ltd. | Angel Extension |
| Honghui Capital | Early Funding |
| Efung Capital | Series A, Angel |
| Shenzhen HTI Group | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2024
Tianjin Venture Capital Management led the round.
- Apr 21, 2023
Honghui Capital participated in the early funding round.
For institutional investors. Book with your work email.
Shenzhen Genocury Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shenzhen Genocury Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Shenzhen Genocury Biotechnology Co., Ltd. a public or private company?
Shenzhen Genocury Biotechnology Co., Ltd. is a private company.
What is the current stock price of Shenzhen Genocury Biotechnology Co., Ltd.?
Shenzhen Genocury Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shenzhen Genocury Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shenzhen Genocury Biotechnology Co., Ltd. worth (valuation)?
Shenzhen Genocury Biotechnology Co., Ltd.'s valuation is estimated at $610.0M based on funding round data.
Can I buy Shenzhen Genocury Biotechnology Co., Ltd. stock?
Shenzhen Genocury Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shenzhen Genocury Biotechnology Co., Ltd.'s last funding round?
Shenzhen Genocury Biotechnology Co., Ltd.'s most recent funding round was Series D on November 1, 2025.
Who are the main investors in Shenzhen Genocury Biotechnology Co., Ltd.?
Key investors in Shenzhen Genocury Biotechnology Co., Ltd. include Tianjin Venture Capital Management Co., Ltd., Efung Capital.
Will Shenzhen Genocury Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shenzhen Genocury Biotechnology Co., Ltd..
How can I track Shenzhen Genocury Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shenzhen Genocury Biotechnology Co., Ltd.'s shares on secondary markets.